Caricamento...
Idarucizumab for a traumatic head injury patient taking dabigatran
BACKGROUND: Dabigatran is one of the four drugs currently used as a direct oral anticoagulant in Japan. Idarucizumab, which specifically targets dabigatran, was recently approved in Japan. We present a case of intracranial hemorrhage in a traumatic brain injury patient taking dabigatran who was trea...
Salvato in:
| Pubblicato in: | Int J Emerg Med |
|---|---|
| Autori principali: | , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer Berlin Heidelberg
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6326148/ https://ncbi.nlm.nih.gov/pubmed/31179930 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12245-018-0202-y |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|